ELUT Q3 2025 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-43.9% YoY

Gross Profit

$2M55.8% margin

Operating Income

-$5M-156.7% margin

Net Income

-$4M-116.4% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

-46.9%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$29M

Total Liabilities

$73M

Stockholders' Equity

-$44M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$6M	-43.9%
Gross Profit	$2M	$3M	-32.4%
Operating Income	-$5M	-$10M	+49.1%
Net Income	-$4M	$1M	-400.8%

Revenue Segments

Women's Health

$2M72%

Cardiovascular

$944,00028%